OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
UPenn Targeting Ultrasensitive Protein Detection at the POC With Microbubbling Digital Assay
A UPenn research team has developed a proof-of-principle detection platform that uses microbubbles to make target protein molecules visible and detectable.
Konica Minolta Launches Precision Medicine Business
KMPJM will provide diagnostic and prognostic testing services based on genes, proteins, and other molecules to aid physicians in assessing and treating patients.
The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.